Back to HighTower Advisors, LLC HighTower Advisors, LLC

QNCXQNCX
Showing 7 of 8 quarters

Position history for HighTower Advisors, LLCHighTower Advisors, LLC's holdings in QUINCE THERAPEUTICS INC

HighTower Advisors, LLC previously held 0 shares of QNCX (QUINCE THERAPEUTICS INC), worth $0 as of 2026-Q1.

Final Value

$0

Final Shares

0

Total Value Change

-$273,000

Total Shares Change

-341,570

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Exited
0
-100.0%
$00.0%$0.10
0
2025-Q4
Increased
328,500
+6.5%
$1.1M0.0%$3.26
27
2025-Q3
Unchanged
308,500
0.0%
$502,8550.0%$1.61
0
2025-Q2
Decreased
308,500
-10.2%
$509,0250.0%$1.55
0
2025-Q1
Increased
343,570
+0.6%
$456,9480.0%$1.35
24
2024-Q4
Unchanged
341,570
0.0%
$638,7360.0%$1.85
0
2024-Q3
Unchanged
341,570
0.0%
$273,0000.0%$0.80
0

Other major holders of QNCX: BNP PARIBAS FINANCIAL MARKETS, Capital World Investors, Capital International Investors, Capital Research Global Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used